Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Details) - Schedule of warrant activity

v3.21.1
Stockholders' Deficit (Details) - Schedule of warrant activity - Warrant [Member]
3 Months Ended
Mar. 31, 2021
USD ($)
$ / shares
shares
Class of Warrant or Right [Line Items]  
Warrant Number of Shares outstanding at beginning | shares 4,033,132
Warrant Weighted Average Exercise Price outstanding at beginning | $ / shares $ 0.97
Warrant Weighted Average Remaining Contractual Term outstanding at beginning 3 years 51 days
Warrant Aggregate Intrinsic Value outstanding at beginning | $ $ 1,350,113
Granted Number of Shares | shares 41,667
Granted Weighted Average Exercise Price | $ / shares $ 0.75
Granted Weighted Average Remaining Contractual Term 3 years 328 days
Granted Aggregate Intrinsic Value | $
Forfeited Number of Shares | shares
Forfeited Weighted Average Exercise Price | $ / shares
Forfeited Aggregate Intrinsic Value | $
Exercised Number of Shares | shares
Exercised Weighted Average Exercise Price | $ / shares
Exercised Aggregate Intrinsic Value | $
Expired Number of Shares | shares
Expired Weighted Average Exercise Price | $ / shares
Expired Aggregate Intrinsic Value | $
Warrant Number of Shares outstanding at ending | shares 4,074,799
Warrant Weighted Average Exercise Price outstanding at ending | $ / shares $ 0.96
Warrant Weighted Average Remaining Contractual Term outstanding at ending 3 years 54 days
Warrant Aggregate Intrinsic Value outstanding at ending | $ $ 2,015,000
Warrant Number of Shares exercisable at ending | shares 2,574,799
Warrant Weighted Average Exercise Price exercisable at ending | $ / shares $ 1.05
Warrant Weighted Average Remaining Contractual Term exercisable at ending 2 years 222 days
Warrant Aggregate Intrinsic Value exercisable at ending | $ $ 1,040,500